<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
60687-239-56
</NDCCode>
<PackageDescription>
10 TRAY in 1 CASE (60687-239-56) > 10 CUP, UNIT-DOSE in 1 TRAY (60687-239-48) > 10 mL in 1 CUP, UNIT-DOSE (60687-239-42)
</PackageDescription>
<NDC11Code>
60687-0239-56
</NDC11Code>
<ProductNDC>
60687-239
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Amantadine Hydrochloride
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Amantadine Hydrochloride
</NonProprietaryName>
<DosageFormName>
SOLUTION
</DosageFormName>
<RouteName>
ORAL
</RouteName>
<StartMarketingDate>
20200831
</StartMarketingDate>
<EndMarketingDate>
20220531
</EndMarketingDate>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA075060
</ApplicationNumber>
<LabelerName>
American Health Packaging
</LabelerName>
<SubstanceName>
AMANTADINE HYDROCHLORIDE
</SubstanceName>
<StrengthNumber>
50
</StrengthNumber>
<StrengthUnit>
mg/5mL
</StrengthUnit>
<Pharm_Classes>
Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2022-06-01
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
20200831
</StartMarketingDatePackage>
<EndMarketingDatePackage>
20220531
</EndMarketingDatePackage>
<SamplePackage>
N
</SamplePackage>
</NDC>